Fortimedix Surgical news

Data Demonstrating Feasibility of symphonX™ Based Surgical Platform for TaCR Announced

Data Demonstrating Feasibility of symphonX™ Based Surgical Platform for TaCR Announced

The studies (n=5) were performed in 2016 and 2017 by internationally renowned surgeon Dr. Karl-Hermann Fuchs, who serves on the company’s Scientific Advisory Board. The results demonstrate that further reduction of abdominal trocars and operative trauma during transanal colon resection is possible and that pure TaCR using a modified version of the symphonX™ surgical platform seems feasible. The data also reveals a promising learning curve, suggesting that clinicians are able to learn the technique of using this platform quickly.  symphonX™ is the world’s smallest single-port surgery solution for use in minimally invasive abdominal laparoscopic surgery. 

“When performing transanal colon resection, it is important to have the right tools that provide sufficient range of motion to reach target anatomies with ease and achieve excellent triangulation for optimal tissue manipulation, retraction and exposure,” said Dr. Karl-Hermann Fuchs, Chief of Surgery at Agaplesion Markus Hospital, Frankfurt am Main. “These cadaver studies show that the symphonX™ based platform enables transanal colon resection with the aid of only a single 5mm transabdominal trocar for visualization. This is an important result that could have positive effects on patient outcomes in terms of post-operative pain, wound complications and hernia development following surgery. We are optimistic that further studies will confirm this finding. The next step will be an in vivo surgery with this modified symphonX™ platform.” 

The results of the studies were also presented at the 25th International Congress of the European Association for Endoscopic Surgery (EAES) in Frankfurt am Main by Dr. Hans F. Fuchs last month.

Go to the News IndexDownload as PDF

By using our website you consent to all cookies in accordance with our Cookie Policy.